Having trouble reading this e-mail? Click here: EFB Newsletter


The EFB President, Executive Board and staff in the Barcelona Central Office wish all of our members every happiness in the festive season, and good health in 2017. We are especially grateful to our many Institutional Members for their support, which is essential for us to increase EFB activity and influence.

The Voice of Biotechnology in Europe

EFB Position Paper on Synthetic Biology

For the European Federation of Biotechnology (EFB) "Synthetic Biology" is not a new and emerging issue, rather it reflects a continuum of advances in biotechnology. The EFB strongly supports the EU aim to promote a knowledge-based bio-economy. We therefore urge European decision makers to provide a framework in which scientific developments, including applications of so-called Synthetic Biology, can flourish while addressing safety concerns for those cases where caution is justified.

EFB supports the commonly-held view that there is no need to develop a new regulatory framework for Synthetic Biology. In those cases where a product incorporating Synthetic Biology falls under the scope of the GMO legislation and/or the Cartagena Protocol on Biosafety, existing regulatory oversight is adequate for current and foreseeable Synthetic Biology applications.

Read the complete document following the link: EFB Position Paper on Synthetic Biology .


Facebook Share    Twitter Tweet    LinkedIn Follow us

Registration now open for meetings organised by the EFB

The EFB Polymer and Bioengineering and Bioprocessing Section (EBBS), and ACIB, have organised a joint conference on Designer Biology to be held in Vienna next June. For detailed information and to register for the meeting please follow the link: Designer Biology.

Register Now

Register Now


Report of the 3rd EFB Applied Synthetic Biology Meeting

Meeting report: 3rd congress on applied synthetic biology in Europe
Costa da Caparica, Portugal, February 2016

In February 2016 the EFB Bioengineering and Bioprocessing Section and the Microbiology Physiology Section held their third joint meeting on advances in Applied Synthetic Biotechnology in Europe (ASBE) in Costa da Caparica, Protugal. Many novel applications were presented during the meeting. They included methods for the development of novel synthetic strains, new synthetic biological tools and synthetic biology applications. The meeting discussed themes such as the shortage of resources and the role of cutting-edge technologies and research in the world